Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A sequential procedure for comparing two experimental treatments with a control.

Emmanuelle Vincent1, Susan Todd, John Whitehead

  • 1Pfizer Global Research and Development, Fresnes Laboratories, France. emmanuelle.vincent@pfizer.com

Journal of Biopharmaceutical Statistics
|November 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response adaptive randomisation in clinical trials: Current practice, gaps and future directions.

Statistical methods in medical research·2025
Same author

Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis.

Rheumatology (Oxford, England)·2024
Same author

Discussion on "The central role of the identifying assumption in population size estimation" by Serge Aleshin-Guendel, Mauricio Sadinle, and Jon Wakefield.

Biometrics·2024
Same author

Impact of dairy fat manipulation on endothelial function and lipid regulation in human aortic endothelial cells exposed to human plasma samples: an in vitro investigation from the RESET study.

European journal of nutrition·2023
Same author

Inverted laser sintering of metal powders.

Scientific reports·2023
Same author

Perspectives on valuing water quality improvements using stated preference methods.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study introduces a novel clinical trial procedure allowing early stopping if an experimental treatment proves superior to control. This method ensures overall error probabilities are controlled during interim analyses for treatments like riluzole in motor neurone disease.

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Neuroscience

Background:

  • Sequential clinical trials require careful statistical design to manage error rates.
  • Adaptive trial designs allow for early termination or modification based on accumulating data.

Purpose of the Study:

  • To describe and validate a procedure for randomized clinical trials with interim analyses.
  • To demonstrate how to control overall error probabilities in such adaptive trial designs.
  • To illustrate the procedure using data from riluzole dose-finding studies for motor neurone disease.

Main Methods:

  • Patients are randomized to two experimental treatments or a control group.
  • Interim analyses compare each experimental treatment against the control.
  • The procedure allows for early stopping or elimination of treatments based on superiority or futility.

Related Experiment Videos

Main Results:

  • The described procedure effectively controls overall error probabilities.
  • It enables the identification of a superior experimental treatment at interim stages.
  • The method is applicable to dose-finding studies, such as those for riluzole in motor neurone disease.

Conclusions:

  • The proposed procedure offers an efficient and statistically sound approach for adaptive clinical trials.
  • It facilitates early decision-making in treatment evaluation while maintaining statistical rigor.
  • This methodology can optimize resource allocation and expedite the identification of effective therapies.